✨
AI Summary
- Vivek Ramaswamy, 31-year-old founder of Roivant Sciences, explores why pharmaceutical companies neglect certain diseases like Alzheimer's despite clear medical need
- He investigates why drug development for women's health has stagnated and remains underserved by major pharmaceutical companies
- Ramaswamy discusses his willingness to assume financial risk in drug research that may fail, prioritizing innovation over guaranteed returns